Abstract: Contributors PART I. Introduction Improving Patient Adherence: State of the Art, With A Special Focus on Medication Taking for Cardiovascular DisordersR. Brian Haynes, MD, PhDPART II. Factors and Interventions Affecting Compliance Chapter 1. Predicting ComplianceDeborah J. Bowen, PhD, Almut Helmes, MS, and Erika Lease, BA Chapter 2. Strategies to Increase Adherence to TreatmentJudith K. Ockene, PhD, MEd Chapter 3. Behavioral Strategies to Improve Medication-Taking ComplianceElizabeth A. Schlenk, PhD, RN, Lora E. Burke, PhD, RN, and Cynthia Rand, PhD, PART III. Multi-Level Organizational Approaches to Compliance Chapter 4. Provider Approaches to Improve ComplianceIra S. Ockene, MD Chapter 5. Organizational Approaches to Improve ComplianceThomas E. Kottke, MD, Leif Solbert, MD, and Milo Brekke, PhD, PART IV. Measurement of ComplianceChapter 6. Conceptual and Methodological ProblemsJacqueline Dunbar-Jacob, PhD, RN, FAAN and Susan Sereika, PhD Chapter 7. Biological MeasuresJohn Urquhart, MD, FRCP (Edin) Chapter 8. Electronic MeasuresLora E. Burke, PhD, MPH, RN Chapter 9. Analysis of Electronic Event Monitored AdherenceSusan M. Sereika, PhD and Jacqueline Dunbar-Jacob, PhD, RN, FAAN Chapter 10. Self-Report DataJames R. Hebert, ScD, Yunsheng Ma, MD, MPH, Cara B. Ebbeling, PhD, Charles E.Matthews, PhD, and Ira S. Ockene, MD PART V. Issues in Special Populations Chapter 11. ChildrenTom Baranowski, PhD, Janice C. Baranowski, MPH, RD, LD, and Karen Cullen, DrPH, RD, LDChapter 12. Minority PopulationsShiriki K. Kumanyika, PhD, MPH, RD Chapter 13. Obese PopulationsMichael G. Perri, PhD PART VI. Issues Across Settings Chapter 14. Clinical TrialsEleanor Schron, MS, RN and Susan M. Czajkowski, PhD Chapter 15. Treatment TargetsHarlan M. Krumholz, MD, Mohsen Davoudi, MD, Joan M. Amatruda, RN, and Sarah A.Roumanis, RN PART VII. Special Topics Chapter 16. Analysis of Clinical Trials and Treatment NonadherenceSusan M. Sereika, PhD and Ed Davis, MD Chapter 17. Compliance of Providers to GuidelinesThomas A. Pearson, MD, PhD and Laurie A. Kopin, ANP Chapter 18. Impact of Compliance on Clinical OutcomesMichel Burnier, MD and Hans R. Brunner, MD Chapter 19. Managed CareThomas H. Lee, MD, MSc PART VIII. Future Directions Chapter 20. Innovative Approaches to ComplianceDeborah J. Aaron, PhD, MSIS, Kimberly A. Morris, PhD, Patricia A. Nixon, PhD, JeffreyP. Martin, MBA, Deborah Echement, BA, and Ronald E. LaPorte, PhD Chapter 21. Future Directions: What Paths Do Researchers Need to Take? What Needs to be Done to Improve Multi-Level Compliance?Neil B. Oldridge, PhD
Publication Year: 2001
Publication Date: 2001-01-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 111
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot